Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
12th February 2021 | Ron Bentsur | 23,419 | Exercise of derivative | $4.25 | $99,530.75 |
12th February 2021 | Ron Bentsur | 23,419 | Open or private sale | $6.36 | $148,944.84 |
11th February 2021 | Ron Bentsur | 1,500 | Open or private sale | $6.28 | $9,420.00 |
25th August 2020 | Ron Bentsur | 1,580 | Open or private sale | $5.95 | $9,406.21 |
24th August 2020 | Ron Bentsur | 3,889 | Open or private sale | $5.68 | $22,104.30 |
21st August 2020 | Ron Bentsur | 3,246 | Open or private sale | $6.05 | $19,650.63 |
20th August 2020 | Ron Bentsur | 3,778 | Open or private sale | $6.29 | $23,779.87 |
19th August 2020 | Ron Bentsur | 6,533 | Open or private sale | $6.32 | $41,265.69 |
18th August 2020 | Ron Bentsur | 4,578 | Open or private sale | $5.83 | $26,691.11 |
17th August 2020 | Ron Bentsur | 4,413 | Open or private sale | $5.72 | $25,226.03 |
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY.